Naohiko Koshikawa

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Venues

Cancer science

Biomarker research

Cancer research communications

Proteomics. Clinical applications

Tokyo Institute of Technology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tokyo Institute of Technology Jun 01 2020

Japan

Professor :: Department of Life Science and Technology

Publications

Nobuaki Funahashi, Hikari Okada, Ryo Kaneko, Kouki Nio, Taro Yamashita, Naohiko Koshikawa
Hepatocyte transformation is induced by laminin γ2 monomer. Cancer science (2024)
Shinya Sato, Masatoshi Nakagawa, Takeshi Terashima, Soichiro Morinaga, Yohei Miyagi, Eisaku Yoshida, Toru Yoshimura, Motoharu Seiki, Shuichi Kaneko, Makoto Ueno, Taro Yamashita, Naohiko Koshikawa
EphA2 Proteolytic Fragment as a Sensitive Diagnostic Biomarker for Very Early-stage Pancreatic Ductal Carcinoma. Cancer research communications 3 (9) (2023)
Kazuki Ikeda, Ryo Kaneko, Eiki Tsukamoto, Nobuaki Funahashi, Naohiko Koshikawa
Proteolytic cleavage of membrane proteins by membrane type-1 MMP regulates cancer malignant progression. Cancer science (2022)
Hoshino Daisuke, Hisamori Kato, Kazuhiro Fukumura, Akila Mayeda, Yohei Miyagi, Motoharu Seiki, Naohiko Koshikawa
Novel LAMC2 fusion protein has tumor-promoting properties in ovarian carcinoma. Cancer science 112 (12) (2021)
Makoto Nagano, Daisuke Hoshino, Jiro Toshima, Motoharu Seiki, Naohiko Koshikawa
NH2 -terminal fragment of ZF21 protein suppresses tumor invasion via inhibiting the interaction of ZF21 with FAK. Cancer science 111 (12) (2020)
Masaki Suzuki, Atsushi Muroi, Masanori Nojima, Ayumi Numata, Hirotaka Takasaki, Rika Sakai, Tomoyuki Yokose, Yohei Miyagi, Naohiko Koshikawa
Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma. Proteomics. Clinical applications 14 (1) (2019)
Masatoshi Nakagawa, Takashi Karashima, Masayuki Kamada, Eisaku Yoshida, Toru Yoshimura, Masanori Nojima, Keiji Inoue, Taro Shuin, Motoharu Seiki, Naohiko Koshikawa
Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer. Biomarker research 5 (2017)

Naohiko Koshikawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Naohiko Koshikawa